Cargando…

Editorial: Influences in the progression of renal cell carcinoma

Detalles Bibliográficos
Autores principales:	Bacchiani, Mara, Grosso, Antonio Andrea, Di Maida, Fabrizio, Masieri, Lorenzo, Minervini, Andrea, Mari, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616685/ https://www.ncbi.nlm.nih.gov/pubmed/36313667 http://dx.doi.org/10.3389/fonc.2022.1059615

Ejemplares similares

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Referee
por: Minervini, Andrea, et al.
Publicado: (2022)

How To Deal with Renal Cell Carcinoma Tumors >7 cm: The Role of Nephron-sparing Surgery
por: Minervini, Andrea, et al.
Publicado: (2021)

Assessing the impact of socio‐economic determinants on access to care, surgical treatment options and outcomes among patients with renal mass: Insight from the universal healthcare system
por: Grosso, Antonio Andrea, et al.
Publicado: (2022)

Robot-assisted partial nephrectomy with 3D preoperative surgical planning: video presentation of the florentine experience
por: Grosso, Antonio Andrea, et al.
Publicado: (2021)

Robotic reconstruction of vesico-urethral anastomosis stenosis: a descriptive technique and short-term results
por: Grosso, Antonio Andrea, et al.
Publicado: (2022)

Robotic Partial Nephrectomy with En Bloc Removal of a Renal Vein Thrombus for Multiple cT3a Renal Cell Carcinoma Lesions
por: Grosso, Antonio Andrea, et al.
Publicado: (2022)

Three-dimensional reconstruction and intraoperative ultrasonography: Crucial tools to safely approach highly complex renal masses
por: Grosso, Antonio Andrea, et al.
Publicado: (2022)

Re: Comparison of immediate vs. deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial
por: Minervini, Andrea, et al.
Publicado: (2019)

Holmium laser ablation of the prostate (HoLAP) with moses technology for the surgical treatment of benign prostatic hyperplasia
por: Grosso, Antonio Andrea, et al.
Publicado: (2021)

How far is too far? Exploring the indications for robotic partial nephrectomy in a highly complex kidney tumor
por: Minervini, Andrea, et al.
Publicado: (2020)

Redo Partial Nephrectomy for Local Recurrence After Previous Nephron-sparing Surgery. Surgical Insights and Oncologic Results from a High-volume Robotic Center
por: Di Maida, Fabrizio, et al.
Publicado: (2023)

Templates of Lymph Node Dissection for Renal Cell Carcinoma: A Systematic Review of the Literature
por: Campi, Riccardo, et al.
Publicado: (2018)

Fibronectin urothelial gene expression as a new reliable biomarker for early detection of local toxicity secondary to adjuvant intravesical therapy for non-muscle invasive bladder cancer
por: Di Maida, Fabrizio, et al.
Publicado: (2021)

Commentary: Early Robotic-Assisted Laparoscopic Pyeloplasty for Infants Under 3 Months With Severe Ureteropelvic Junction Obstruction
por: Sforza, Simone, et al.
Publicado: (2021)

Editorial: Immunotherapy in renal cell carcinoma
por: Gruenwald, Viktor, et al.
Publicado: (2022)

Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current Evidence
por: Bacchiani, Mara, et al.
Publicado: (2023)

Predictors of early catheter replacement after HoLEP. Results from a high-volume laser center
por: Maida, Fabrizio Di, et al.
Publicado: (2023)

Letter to the Editor: “Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection”
por: Di Maida, Fabrizio, et al.
Publicado: (2020)

Patterns and Predictors of Optimal Surgical and Functional Outcomes after Holmium Laser Enucleation of the Prostate (HoLEP): Introducing the Concept of “Trifecta”
por: Grosso, Antonio Andrea, et al.
Publicado: (2023)

Editorial: Case reports in renal cell carcinoma
por: Zhuang, Tony Z., et al.
Publicado: (2023)

Oncological impact of inflammatory biomarkers in elderly patients treated with radical cystectomy for urothelial bladder cancer
por: Mari, Andrea, et al.
Publicado: (2020)

Editorial: Immune checkpoint inhibitors in renal cell carcinoma
por: Tykodi, Scott S., et al.
Publicado: (2023)

Editorial: Long-non coding RNAs in renal cell carcinoma
por: Wang, Zongping, et al.
Publicado: (2022)

Editorial: Molecular and immune influences in the progression of gliomas
por: Malik, Karan, et al.
Publicado: (2023)

Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)
por: Meagher, Margaret F., et al.
Publicado: (2023)

Editorial: Therapies and influences in urothelial carcinoma
por: Ozgun, G., et al.
Publicado: (2022)

How Atypical Penile Curvature Influence Clinical Outcomes in Patients with Peyronie's Disease Receiving Collagenase Clostridium Histolyticum Therapy?
por: Cocci, Andrea, et al.
Publicado: (2020)

Editorial: Establishment of marker models for molecular typing of renal cell carcinoma
por: Jiang, Aimin, et al.
Publicado: (2023)

The Natural History of Peyronie's Disease
por: Di Maida, Fabrizio, et al.
Publicado: (2021)

Editorial: Molecular genetics and therapeutic advances in renal carcinoma
por: Nanus, David M., et al.
Publicado: (2023)

Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges
por: Santoni, Matteo, et al.
Publicado: (2019)

Holmium laser enucleation of the prostate (HoLEP) is safe and effective in patients with high comorbidity burden
por: Maida, Fabrizio Di, et al.
Publicado: (2023)

Editorial: Advances in the understanding and treatment of cutaneous lymphoma
por: Bernardelli, Andrea, et al.
Publicado: (2023)

Exploring the Diversity and Predictors of Histopathological Findings Across the European Association of Urology Guidelines Office Rapid Reaction Group Priority Groups for Patients with Renal Tumors: Implications for Individualized Prioritization of Renal Cancer Care
por: Campi, Riccardo, et al.
Publicado: (2021)

Rapid recurrence and radiographic progression of sarcomatoid renal cell carcinoma
por: Edelson, Mia P., et al.
Publicado: (2017)

Editorial: The ever-changing scenario of first line treatment of metastatic renal cell carcinoma
por: Vitale, Maria Giuseppa, et al.
Publicado: (2023)

Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice
por: Roberto, Michela, et al.
Publicado: (2021)

Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinoma
por: Lindner, Andrea Katharina, et al.
Publicado: (2022)

The impact of COVID-19 on the male genital tract: A qualitative literature review of sexual transmission and fertility implications
por: Verrienti, Pierangelo, et al.
Publicado: (2022)

Editorial: PTCL from genes to therapy
por: Janikova, Andrea
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dmt2ubknir964lb5f27j75aqth